Issue #1 2016 – Digital edition
Posted: 29 February 2016 | European Pharmaceutical Review | 2 comments
In Issue #1 2016: Regulation, Drug Delivery, Raman, PAT, Formulation, NIR, Microbiology, and much more…
- FOREWORD: The evolving pharmacopoeia
David Elder, GlaxoSmithKline and JPAG - REGULATORY INSIGHT: Four trends that will transform healthcare in Europe in 2016
Warren Hochfeld, Jenna Riffell and Neil Levinson, Kaiser Associates - DRUG DELIVERY: The role of drug transporters at the blood brain barrier
Jasminder Sahi and Yi Li, Sanofi R&D - IN-DEPTH FOCUS: RAMAN
With articles from Nikolaos Scoutaris, University of Greenwich, Ye Ying, Shanghai Normal University, Anna Łuczak, Bristol Myers Squibb and Zafar Iqbal, New Jersey Institute of Technology. Turn to page 32 for a Raman roundtable - PAT SERIES: The application of skip-testing to drug substance manufacture
Phil Borman, Simon Bate and Keith Freebairn, GlaxoSmithKline - FORMULATION: Dissolution testing in the modern world
Juliet Symonds and David Elder, GlaxoSmithKline - IN-DEPTH FOCUS: NIR
Featuring contributions from Jian X. Wu and José Manuel Amigo, University of Copenhagen, Manel Bautista, Novartis Pharma AG, and Menghuan Li and Yanli Zhao, Nanyang Technological University. An NIR Q&A can be found on page 56 - MICROBIOLOGY SERIES: The challenges of risk-based environmental monitoring in sterile product filling
James L. Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society
The digital version of Issue #1 2016 is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
thank u very much
Appreciate to know your EPR magazine, thanks,